Livv review

Take a quarter dose here and you pay what the top dose costs — Livv states it outright, and unusually, it also publishes the numbers that let you check. Its semaglutide comes in five strengths starting at 0.2 mg, its tirzepatide in seven, and every one of them carries the same monthly figure. That makes the lowest strength a sixth of the highest for identical money. Printing the ladder at all is uncommon here, and printing it while charging flat is a real service to a reader who wants to know what they are buying. Three things will cost you. The figure on the category page is a six-month prepay and the month-to-month rate runs 18% above it. Subscriptions renew even if you have not completed what is needed to keep a prescription active, so you can be billed while unprescribable. And the strength is the provider's choice, not yours.

Vs median

$10/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

Livv does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Livv sells compounded semaglutide and compounded tirzepatide as weekly injections on one-, three- and six-month plans, shipping to 44 states plus Puerto Rico. It is one of very few sellers that publishes the actual list of strengths it dispenses — five for semaglutide starting at 0.2 mg, seven for tirzepatide — and states plainly that all of them are priced the same, with the provider rather than the patient choosing which one you get. It publishes a LegitScript ID and a monthly batch-potency tolerance. No compounding pharmacy is named.

ALL DOSES ARE PRICED THE SAME, in the seller's own words: "All doses are priced the same, so your plan is guided by what's medically appropriate, not cost." The 0.2 mg strength is billed at the same rate as 1.2 mg — six times the drug for identical money

• THE HEADLINE IS A SIX-MONTH PREPAY. The category page leads with $135/month; the standing month-to-month rate is $159, 18% higher
• "Subscriptions renew automatically unless canceled—even if required actions to maintain an active prescription are not completed" — you can be billed while you are not in a position to be prescribed to
• "Note that patients do not self-select doses" — the strength you receive is the provider's call, so a deliberate low dose is a conversation and not a checkout option
• No compounding pharmacy is named — only "US-licensed, FDA-regulated compounding pharmacies"
• Whether the 3- and 6-month plans are charged up front or monthly is not stated on the product page
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Livv is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan